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Abstract
Reproduction involves the integration of hormonal signals acting across multiple systems to 
generate a synchronised physiological output. A critical component of reproduction is the 
luteinising hormone (LH) surge, which is mediated by oestradiol (E2) and neuroprogesterone 
interacting to stimulate kisspeptin release in the rostral periventricular nucleus of the third 
ventricle in rats. Recent evidence indicates the involvement of both classical and membrane E2 and 
progesterone signalling in this pathway. A metabolite of gonadotrophin-releasing hormone 
(GnRH), GnRH-(1-5), has been shown to stimulate GnRH expression and secretion, and has a role 
in the regulation of lordosis. Additionally, gonadotrophin release-inhibitory hormone (GnIH) 
projects to and influences the activity of GnRH neurones in birds. Stress-induced changes in GnIH 
have been shown to alter breeding behaviour in birds, demonstrating another mechanism for the 
molecular control of reproduction. Peripherally, paracrine and autocrine actions within the gonad 
have been suggested as therapeutic targets for infertility in both males and females. Dysfunction of 
testicular prostaglandin synthesis is a possible cause of idiopathic male infertility. Indeed, local 
production of melatonin and corticotrophin-releasing hormone could influence spermatogenesis 
via immune pathways in the gonad. In females, vascular endothelial growth factor A has been 
implicated in an angiogenic process that mediates development of the corpus luteum and thus 
fertility via the Notch signalling pathway. Age-induced decreases in fertility involve ovarian 
kisspeptin and its regulation of ovarian sympathetic innervation. Finally, morphological changes in 
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the arcuate nucleus of the hypothalamus influence female sexual receptivity in rats. The processes 
mediating these morphological changes have been shown to involve the rapid effects of E2 
controlling synaptogenesis in this hypothalamic nucleus. In summary, this review highlights new 
research in these areas, focusing on recent findings concerning the molecular mechanisms 
involved in the central and peripheral hormonal control of reproduction.
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Introduction
Reproduction is tightly regulated by the actions of hormones, both central and peripheral in 
origin. The ‘classical’ mechanisms of steroidal control of reproduction have been studied for 
decades, yet questions remain about how these hormones interact within the nervous system 
to elicit a coordinated response leading to ovulation and fertilisation. The common final 
pathway to the regulation of reproductive function is dependent on the appropriate 
functioning of the hypothalamic-pituitary-gonadal (HPG) axis. The proper coordination of 
the HPG axis relies largely on the inputs that regulate gonadotrophin-releasing hormone 
(GnRH) release from hypothalamic neurones. In recent years, numerous nonclassical 
mechanisms have been uncovered, including newly understood membrane, autocrine and 
paracrine actions of steroid hormones. In addition, novel neuropeptides have been added to 
the list of neuroendocrine mediators such as the truncated GnRH [GnRH-(1-5)], as well as 
the inhibitory gonadotrophin release-inhibitory hormone (GnIH). Together, these recently 
appreciated events have changed our understanding of the interaction of the HPG axis and 
the relationship between the periphery and the central nervous system in the regulation of 
reproduction.
Control of the LH surge
Central nervous system (CNS) regulation of the LH surge
As reviewed previously, oestradiol membrane signalling, comprising oestradiol (E2) 
signalling that is initiated at the cell membrane, plays an important role in the CNS synthesis 
of progesterone (neuroP) needed for oestrogen positive-feedback of the LH surge (1). 
Although the preovulatory rise in circulating E2 is essential for stimulating gonadotrophin 
release (2–4), progesterone is also necessary for the LH surge (5–9). In ovariectomised rats 
and mice, E2 induces an LH release (10) and LH levels are augmented by additional 
application of progesterone (11,12). Blocking progesterone receptor (PR) or progesterone 
synthesis prevents the E2-induced GnRH and LH surges in ovariectomised rats (5,13) and 
arrests the oestrous cycle in intact female rats (14). Most critically for this discussion, 
ablation of PR in kisspeptin (KP)-expressing neurones abrogates oestrogen positive-
feedback (15), indicating that that both E2 and progesterone are necessary for surge release 
of LH.
Rudolph et al. Page 2
J Neuroendocrinol. Author manuscript; available in PMC 2016 December 09.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Where does neuroP act to influence the LH surge? It is well established that GnRH neurones 
themselves do not express the requisite steroid hormone receptors, oestrogen receptor (ER)α 
and PR (16,17). There is now solid evidence that the LH surge ‘pattern generator’, which 
integrates steroid hormone information and regulates oestrogen positive-feedback is a 
population of KP-expressing neurones of the rostral periventricular nucleus of the third 
ventricle (RP3V), an area that includes the anterior periventricular nucleus and the 
anteroventral periventricular nucleus (18–25). Kiss1 neurones in the RP3V are critical for 
GnRH secretion because KP released from Kiss1 neurones activates GnRH neurones via 
GPR54, a G-protein coupled receptor that binds KP (26–28). Although much of the work on 
steroid regulation of KP and its gene, Kiss1, has focused on E2 (29,30), it is now evident that 
E2 and neuroP function together to regulate KP. First, both ERα and PR are needed for 
positive-feedback of the LH surge (31,32), and both have been localised in KP neurones, 
although neither are found in GnRH neurones (20,33). Consistent with the need for E2-
induced PRs for the LH surge, a substantial number of KP neurones in RP3V and the arcuate 
nucleus of the hypothalamus (ARH) express PR after E2 treatment (25,30,33,34). Coincident 
with this, rising E2 levels during pro-oestrus induce neuroP synthesis (14,35).
A combination of in vitro and in vivo experiments have demonstrated that neuroP acts on 
KP neurones to mediate oestrogen positive-feedback (Fig. 1). Integrated steroid signalling 
was studied in a cell line (mHypoA51s) that approximates ‘sexually mature’ female 
hypothalamic neurones. These immortalised neurones have the characteristics of post-
pubertal RP3V KP neurones because they express ERα, PR and KP (36). As with KP 
neurones in vivo, E2 and the ERα agonist, PPT, induced KP and PR in mHypoA51s. 
Significantly, E2-induced PR up-regulation was dependent on an intracellular ER, whereas 
KP expression was stimulated by membrane-impermeable E2 (E2 coupled to bovine serum 
albumin; E-6-BSA). These data suggest that anterior hypothalamic KP neurones utilise both 
membrane-initiated and classical nuclear oestrogen signalling to up-regulate KP and PR, 
which are essential for the LH surge.
The nature of progesterone signalling in KP neurones remains to be clarified. In addition to 
classical nuclear PR, there are intriguing suggestions that KP neurones in vitro and in vivo 
have membrane progesterone receptors, especially mPRβ (37). The mPRs are seven-
transmembrane proteins that activate G proteins that belong to the progestin and adipoQ 
receptor (PAQR) family not the classic G protein-coupled receptor (GPCR) family (38–40). 
PAQRs can signal through mitogen-activated protein kinase activation and increasing [Ca2+]i 
(41–47); but see also (48). Studies in mHypoA51s indicate that classical PR is responsible 
for progesterone-induced signalling events. Treatment of E2-primed mHypoA51s with 
progesterone induces a rapid increase in free cytoplasmic calcium ([Ca2+]i), which appears 
to be responsible for the release of KP induced by progesterone, whereas inhibition with 
RU486 prevents the [Ca2+]i increase (36).
In vivo, preliminary experiments have demonstrated that exogenous progesterone rescued 
the LH surge in females whose hypothalamic steroidogenesis was blocked with the 
CYP11A1 inhibitor aminoglutethimide (AGT) (49). In AGT-treated animals, infusions of 
progesterone or KP into the diagonal band of Broca induced an LH surge, confirming that 
KP operates downstream of neuroP. Finally, KP knockdown in the RP3V prevented the E2-
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induced LH surge (49). Most importantly, the ablation of PR in KP neurones in 
ovariectomised mice abrogates E2 positive-feedback (15) demonstrating that that both E2 
and neuroP are necessary for the surge release of LH.
Molecular mechanisms of GnRH-(1-5) action
The decapeptide GnRH (pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2) is highly 
conserved across species, suggesting its functional importance throughout evolution (50). 
GnRH is primarily known for its role in regulating reproductive function and behaviour via 
interaction with KP and its cognate receptor, GPR54, in the hypothalamus (51–57). Within 
each oestrous cycle, a rapid increase in GnRH secretion culminates in an LH surge, which 
precedes the onset of sexual receptivity and ovulation. In addition to its effects on the 
secretion of LH, GnRH can autoregulate its own biosynthesis and secretion via an ultrashort-
loop feedback mechanism (58–62).
GnRH not only functions in its full form, but also can signal via its metabolite, GnRH-(1-5). 
GnRH-(1-5) is produced by the cleavage of GnRH by the zinc metalloendopeptidase 
EC3.4.24.15 (EP24.15) at the covalent bond linking the fifth and sixth amino acids (63–65) 
(Fig. 2). Localisation of EP24.15 supports the involvement of EP24.15 in the modulation of 
hypothalamic GnRH neuronal function (63,66). EP24.15 immunoreactivity is sensitive to 
hormonal fluctuations: increasing on pro-oestrous day of the rat oestrous cycle within the 
median eminence, with a peak expression coinciding with the LH surge (63). Unlike GnRH, 
GnRH-(1-5) robustly stimulates GnRH gene expression (67) and stimulates GnRH secretion 
(68). Moreover, the GnRH facilitation of lordosis behaviour is actually mediated by its 
metabolism to GnRH-(1-5) (69).
Interestingly, studies show that GnRH-(1-5) does not bind to the GnRH receptor (51) but 
binds to two orphan GPCRs: GPR101 (70) and GPR173 (71,72) (Fig. 2). Both GPR101 and 
GPR173 are members of the Rhodopsin class of receptors. The Rhodopsin family is the 
largest of the five groups of orphan receptors with 672 members of which 63 have no known 
ligands. Both GnRH-(1-5)-binding GPCRs are highly conserved and are highly expressed in 
the hypothalamus (Allen Brain Bank) (73,74). In several species, the coding sequence for 
GPR101 is located on the X chromosome in a band that is syntenic between species (75). In 
mouse, GPR101 mRNA is 2186 bases, encoding a seven-transmembrane receptor that is 
approximately 51 kDa (76). The sequenced GPR173 mRNA is 1122 bases, which translates 
to a 42-kDa seven-transmembrane receptor (73). Functional studies suggest that GnRH-(1-5) 
retards the cellular migration of neural cells via GPR173 (71–73). By contrast, GnRH-(1-5) 
may stimulate cellular migration and invasion of the extracellular matrix in endometrial cells 
via GPR101 (70,77).
These studies support the idea that GnRH-(1-5) represents another layer of regulatory 
complexity in tissues where GnRH is also produced. The identification of an endogenous 
ligand to an orphan GPCR is important because these receptors may have therapeutic 
potential (74). Furthermore, the identification of a GPCR that binds GnRH-(1-5) may help 
resolve some of the current quandaries regarding the actions of GnRH (agonist/antagonist) 
and enhance our understanding in the evolution of peptide metabolism and processing.
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Role of GnIH in avian reproductive system; regulation of GnIH by photoperiod and stress 
and the effects of these changes on reproductive behaviours
Although GnRH and its metabolite, GnRH-(1-5), are known for promoting reproduction-
related functions in the HPG axis, a more recently discovered hormone has been implicated 
as a potential brake on the HPG system. GnIH has received attention because of its role in 
the inhibition of activity of components of the HPG axis, including a reduction of sexual 
behaviour (78–86). Despite a great deal of investigation into its specific functions and the 
factors that regulate GnIH, the full range of actions of GnIH within the central nervous 
system remain unknown. At present, we know that, in birds, GnIH projects to GnIH 
receptor-expressing GnRH-I and -II neurones in addition to the median eminence (84,87). In 
several species of mammals, GnIH projects to and also influences the activity of GnRH 
neurones (85,88), as well as the external layer of the median eminence (88–92), although 
this latter finding remains disputed (85,93). There are GnIH projections to multiple other 
brain areas (e.g. brainstem) and possibly to the spinal cord (84,93), although the function of 
GnIH in these extra-hypothalamic areas remains obscure. The GnIH content of the brain is 
influenced by changes in day length and the associated changing melatonin signal in 
seasonal breeders (84,94–99). In birds, despite the influence of GnIH on GnRH neurones, it 
appears that GnIH does not influence the termination of reproduction at the end of the 
breeding season. Rather, it is more likely that GnIH plays a role in temporary reproductive 
suppression within the breeding season in response to different physiological stimuli, such 
as stress (84,100–102).
The action of GnIH is not restricted to the brain and the anterior pituitary gland. GnIH and 
its receptor (GPR147) are synthesised in the gonads of both sexes of all vertebrates studied 
to date (103–108). Furthermore, in birds, GnIH-producing neurones in the brain project to 
the pars nervosa, suggesting that GnIH is released directly into the bloodstream (G. Bentley, 
unpublished observations). If confirmed, then not only can locally produced GnIH act within 
the gonads, but also neurally produced GnIH could be released to the general circulation and 
act upon peripheral targets.
It is possible that GnIH-producing neurones can be subdivided into heterogenous 
subpopulations that respond to unique environmental and physiological cues. For example, 
GnIH neurones express melatonin receptor (MelR) and glucocorticoid receptor (GR) 
mRNA. However, not all of the GnIH neurones express MelR or GR (98,109) and it is not 
known whether single GnIH neurones can express both MelR and GR, suggesting that there 
could be MelR- and GR-specific subpopulations of GnIH neurones, each with potentially 
distinct functions. Thus, it remains to be determined whether or how melatonin and 
glucocorticoids interact to influence GnIH action within the brain.
In birds and mammals, melatonin and corticosterone can act on the gonadal GnIH system. 
This suggests the possibility that the neural and gonadal GnIH systems could differentially 
respond to hormones and, together, could coordinate a response to circulating hormones 
(perhaps via direct innervation of the gonad). Unfortunately, only in vitro preparations can 
be used to answer this question. Without separating the gonads from the blood circulation 
and from potential neural input, it is impossible to determine gonadal responses to a 
changing hormonal environment, especially if GnIH is present in circulating blood. 
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However, in vivo studies in this area could also be very informative, especially if localised 
blockade of GnIH receptor could be induced in the gonads.
GnIH responses to chronic stress have been documented in male and female rats, with a 
significant impact on reproduction (109–111). To date, there has been only one study on 
chronic stress effects upon GnIH in birds with sex-specific effects of treatment. Female 
European starlings (Sturnus vulgaris) exhibited increased ovarian GnIH expression 
compared to their nonstressed counterparts and were also reported not to ovulate, whereas 
nonstressed animals did (111). Acute stressors can certainly influence the avian GnIH 
system, although these effects appear to depend on the species, the time of year, the sex of 
the bird and the stressor (112–114). In addition, some stressors influence the gonads directly 
rather than via neural GnIH (112). The same is true for chronic housing stress in European 
starlings, as noted above (111). Thus, it is clear that neural and GnIH systems can respond 
differently to any particular stressor, regardless of whether it is acute or chronic. Further 
studies in this area should determine the response of gonadal and neural GnIH systems to 
stressors and hormones, and should also assess communication between these GnIH systems 
in a variety of species.
Local regulation of gonadal function
Autocrine and paracrine regulation of testicular function: molecular pathways involved in 
testis pathophysiology leading to infertility
Gonadotrophins are key regulators of male gonadal function. LH and follicle-stimulating 
hormone (FSH) released from the pituitary reach the testis and exert their effects through 
receptors located in the plasma membrane of Leydig and Sertoli cells, respectively 
(115,116). In addition, local factors and hormones influence testicular function via paracrine 
and autocrine mechanisms. Several molecules that reach the testis and/or are locally 
produced in the gonad regulate the activity of different cell types (e.g. Leydig cells, Sertoli 
cells, mast cells, macrophages, myofibroblasts), include peptides (117), neurotransmitters 
(118), neurohormones (119), cytokines (120) and prostaglandins (PGs) (121).
In this context, the neurohormones serotonin (122), melatonin (123) and corticotrophin-
releasing hormone (CRH) (124) act in the testes as important negative regulators of cAMP 
and androgen production. Serotonin, melatonin and CRH can be produced within the CNS 
and secreted into peripheral circulation, or locally synthesised in the testes (125,126). 
Melatonin and also serotonin inhibit steroidogenesis via their 5-HT2 receptor- and Mel1a 
receptor-mediated signalling pathways, which influence CRH centrally (125,127) and in the 
testes (127,128). This CRH-mediated inhibition of steroid production occurs through the 
activation of tyrosine phosphatases, which reduces the phosphorylation of extracellular 
regulated kinase (ERK) and c-Jun N-terminal kinase, and subsequently down-regulates c-
jun, c-fos and steroid acute regulatory protein (StAR), thereby inhibiting testosterone 
production (128).
Melatonin has been postulated to have a physiological role as a paracrine signalling 
molecule, directly regulating the production of factors (e.g. immune, interleukin-2) in its 
immediate vicinity (129). Recent observations show that melatonin modulates local cellular 
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activity in testicular immune cells, inducing the expression of antioxidant enzymes and 
reducing the generation of reactive oxygen species in mast cells. In testicular macrophages, 
melatonin inhibits cell proliferation, the expression of proinflammatory cytokines, 
interleukin-1β and tumour necrosis factor α, and PG production (130). PGs are derived from 
arachidonic acid by the action of inducible isoenzyme cyclooxygenase (COX). In testicular 
biopsies of men with impaired spermatogenesis, COX-2 is expressed in immune cells, 
highlighting their relevance in testicular inflammation associated with idiopathic infertility 
(131). Furthermore, Leydig and Sertoli cells also produce PGs and express several 
prostanoid receptors (132,133), suggesting autocrine/paracrine action in testicular somatic 
cells.
PGD2 has a stimulatory effect on basal testosterone production in Leydig cells (134), 
whereas PGF2α exerts an inhibitory role in the expression of the StAR and 17β-
hydroxysteroid dehydrogenase (HSD), as well as in the synthesis of testosterone induced by 
human chorionic gonadotrophin (hCG)/LH (133), demonstrating that the role of PGs on 
steroidogenesis, spermatogenesis and ultimately fertility depends on the specific PG in 
question.
Recent research indicates that multiple local signals influence testicular physiology and are 
involved in the pathogenesis or maintenance of human infertility. Notably, male infertility 
results from endocrine dysfunctions associated with the hypothalamic-pituitary-testicular 
axis only in a small number of cases (135), suggesting the source of infertility likely occurs 
within local, intra-testicular pathways. Thus, new insights about how cell–cell interactions 
within the testes affect testicular function and fertility will contribute to the understanding of 
male reproductive physiopathology, and future studies focusing on testicular paracrine and 
autocrine interactions may lead to new therapeutic approaches to idiopathic male infertility.
Follicular development, corpus luteum and progesterone regulation of ovarian 
vascularisation and molecular pathways involved
Similar to testicular functions including spermatogenesis and steroidogenesis, ovarian 
follicular development and regression is a continuous and cyclic process that depends on a 
number of endocrine, paracrine and autocrine signals. In healthy tissues, physiological 
angiogenesis is mainly limited to the reproductive system. The ovarian vasculature is closely 
associated with preovulatory follicle and corpus luteum during the ovarian cycle and is one 
of the few sites where nonpathological development and regression of blood vessels occurs 
in the adult. Recently, local factors such as vascular endothelial growth factor A (VEGF-A) 
and angiopoietins, which act specifically on vascular endothelial cells or pericytes and 
smooth muscle to control angiogenesis or angiolysis, were identified in the growing follicle 
and corpus luteum of several species, including humans (136).
VEGF-A is a key angiogenic factor involved in the formation of new blood vessels within 
many tissues. It is required to initiate the formation of new immature vessels by promoting 
endothelial cell proliferation and vascular permeability. Inhibition of VEGF-A and 
angiopoietin 1 (ANGPT1) action in rat ovaries by intrabursal administration of VEGF-A-
Trap or ANGPT1 antibodies, respectively, produces an imbalance in the ratio of anti-
apoptotic : pro-apoptotic proteins leading to greater follicular atresia (137,138). In addition, 
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VEGF-A prevents apoptosis and stimulates the proliferation of granulosa and theca cells of 
antral follicles through a direct interaction with its KDR receptor localised in granulosa 
cells, a pathway that involves phosphoinositide 3-kinase (PI3K)/AKT (139). Furthermore, in 
vitro studies performed in early antral follicles and granulosa cell cultures isolated from rat 
demonstrate that VEGF acts directly on follicular cells synergistically with FSH and E2, 
preventing apoptosis and stimulating proliferation, thus promoting follicular development 
and the selection of the follicle to ovulate (140). Such work reported a direct role for VEGF 
in early antral follicles mediated by the PI3K/AKT and ERK1/2 pathways, besides the 
classical and well known proangiogenic function. Together, these data support the notion 
that angiogenic factors have an important role in controlling ovarian function.
In vitro studies have shown that Notch signalling is critical for the survival of luteal cells 
isolated from pregnant rats (141). Local Notch inhibition decreases progesterone levels and 
cell survival, confirming that Notch has a direct action on both steroidogenesis and luteal 
viability (141). The Notch signalling pathway is a cell–cell communication pathway that is 
evolutionarily conserved from Drosophila to humans. To date, four different Notch receptors 
(Notch 1, 2, 3 and 4) and five different ligands (Jagged-1 and -2 and DLL-1 -3 and -4) have 
been identified in mammals. This Notch system regulates cell fate, proliferation and death. 
The Notch genes encode transmembrane receptors, which, upon binding their ligand, are 
cleaved, releasing the intracellular domain. The intracellular portion of the receptor 
translocates to the nucleus to act as a transcriptional coactivator, regulating cell fate genes 
(142).
Moreover, in the rat, there is an interaction between the Notch signalling pathway and 
progesterone that maintains the functionality of the corpus luteum (143). Notch signalling 
augments P450scc synthesis, leading to an increased synthesis of progesterone, which in 
turn regulates the activated intracellular Notch domain. Thus, Notch induces progesterone 
production in vitro through the activation of cytochrome P450 cholesterol side chain 
cleavage enzyme (P450scc) and decreases apoptosis-mediated cell death. This is the first 
evidence that there is cross-talk between the Notch signalling system and progesterone, 
which increases the survival of luteal cells. Also, the Notch/PI3K/AKT signalling pathway 
might be interacting with progesterone, intensifying the survival role of this hormone in 
luteal cells. Nevertheless, future studies are required to thoroughly investigate this newly 
discovered Notch-progesterone relationship and how it contributes to ovarian function and 
reproduction as a whole.
Ovarian kisspeptin and its role in follicular development
Reproduction in females requires an LH surge, which is centrally regulated by KP. However, 
KP is found in many peripheral organs (144,145), in particular, the ovary, which expresses 
KP and its receptor, GPR54, suggesting a role for KP in the peripheral control of 
reproductive events. KP expression in the ovary fluctuates throughout the oestrous cycle, 
strongly suggesting that it may be involved locally in the ovulatory cycle and luteinisation 
(146–148); but see also (28). However, the mechanisms of action of KP in the ovary, such as 
paracrine or autocrine functions remain largely unknown.
Rudolph et al. Page 8
J Neuroendocrinol. Author manuscript; available in PMC 2016 December 09.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A recent study demonstrated that intraovarian administration of a KP antagonist (p234) 
delays vaginal opening and alters the oestrous cycle in rats (147). Additionally, local 
administration of exogenous KP decreases antral follicle and corpora lutea number in fertile 
and subfertile rats, which was reversed by p234 treatment, suggesting that KP also 
participates in both follicular development and ovulation at the level of the ovary (149). 
Moreover, during ovulation in humans and nonhuman primates, ovarian KP and GPR54 
mRNA increases with other ovulation-associated genes, such as COX-2 and progesterone 
receptor. The ovarian administration of the COX-2 inhibitor, indomethacin, disrupted the 
ovulatory process in rats, supporting the idea of a local role of KP and GRP54 in ovulation 
(150). It appears that KP regulates progesterone secretion from luteal cells as well. In 
isolated chicken granulosa cells, KP stimulates progesterone secretion, possibly by directly 
altering levels of steroidogenic enzymes, including StAR, P450scc, which converts 
cholesterol to pregnenolone, and 3β-HSD (151), which converts pregnenolone to 
progesterone. Similarly, in rat luteal cells, KP increased progesterone production via 
ERK1/2 signalling and increased the expression of StAR and CYP11A mRNA (152). 
Furthermore, administration of a GPR54 antagonist, p234, inhibited progesterone secretion 
in granulosa cell cultures treated with hCG, implicating KP in the luteinisation of granulosa 
cells (148). Together, these data suggest a potential role of KP in the local control of ovarian 
function, potentially via progesterone synthesis. These and future studies involving paracrine 
and autocrine actions of ovarian KP will clarify the molecular mechanisms involved in the 
regulation of follicular development and ovulation during reproductive life and ovarian 
ageing.
Although a decreased follicular pool indicates physiological ageing of the ovary (153), an 
increased rate of follicular loss is also a pathology that affects the follicular reserve pool, and 
thereby fertility, in humans and other mammals (154). Reproductive ageing in women begins 
with shortened menstrual cycles, smaller increases in FSH and decreased levels of inhibin 
(155), which results in accelerated follicular growth and premature exhaustion of the 
follicular pool. One of the mechanisms involved in ovarian ageing is increased sympathetic 
nerve activity. Ovaries of postmenopausal women (≥ 51 years old) have a higher density of 
innervation compared to age-matched controls (156,157). In the rat, reproductive ageing is 
associated with increased ovarian sympathetic activity, which is strongly correlated with the 
spontaneous appearance of follicular cysts and a loss of preantral follicles (158,159). Indeed, 
the highest sympathetic innervation is found in postmenopausal women, suggesting a 
correlation between ageing-induced infertility and sympathetic nerve activation. Recent 
findings indicate that sympathetic innervation may be controlling age-induced infertility via 
regulation of KP because ovarian sympathectomy diminishes KP levels (A. Paredes, 
unpublished observations). Additionally, during reproductive ageing, KP expression in the 
ovary increases from the subfertile to infertile period and is directly correlated with the 
increase in ovarian norepinephrine observed with ageing (149,158), suggesting that KP may 
be directly controlled by sympathetic innervation of the ovary (147), as well as supporting 
the idea that KP is regulated by the adrenergic system and that both the adrenergic system 
and KP participate in the local regulation of follicle development and ovulation during 
reproductive ageing. Furthermore, KP is involved in follicular dynamics: intraovarian 
administration of KP produced an increase in the numbers of corpora lutea and type III 
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follicles in fertile and subfertile periods, which was reversed by KP receptor antagonism. 
Future studies should address the potential autocrine and paracrine roles of KP in the ovary, 
specifically the interaction of KP, steroidogenic pathways and sympathetic innervation and 
how they relate to reproductive outcomes across the lifespan.
Morphological changes in ARH initiated by oestradiol membrane signalling that mediate 
lordosis behaviour
Another key component to reproduction in rodents is female sexual receptivity, which is 
mediated by E2-dependent alterations in hypothalamic neuronal structure. Although the 
molecular bases of E2-dependent facilitation of female sexual receptivity have more recently 
been described in detail, the understanding that steroid hormones exert behavioural effects 
via changes in neural morphology is a well established phenomenon. The most well known 
example of E2-induced changes in dendritic structure regulating memory-related behaviour 
is from the hippocampus (160), whereas E2-induced changes in dendrites in the 
hypothalamus have also been known for some time (161). Indeed, changes in dendritic 
morphology are critical for the lordosis-regulating circuit (162), which extends from the 
ARH to the medial preoptic nucleus (MPN), to the ventromedial nucleus of the 
hypothalamus (VMH). Recent studies have begun to clarify the molecular mechanisms by 
which morphological changes in the ARH-MPN-VMH circuit allow for expression of 
lordosis behaviour. The primary step of E2 signalling in the ARH occurs via ERα 
transactivation of mGluR1a, which initiates morphological changes that are coincident with 
and required for the display of lordosis behaviour. Within 4 h after E2 treatment, immature, 
filapodia-like dendritic spines are formed in the ARH (162). Twenty-four hours after E2 
treatment, there is a shift in the proportion of dendritic spines, with a decrease in filapodia 
and a concomitant increase in mature, mushroom-shaped spines (162). The formation of new 
spines is necessary for the E2-induced lordosis because blocking spine formation 
significantly reduces the expression of sexual receptivity (162).
Although it appears that spinogenesis is initiated by the action of E2 at membrane ERα, it is 
unclear what molecular mechanisms underlie spine maturation. Evidence from other circuits 
suggests a role for the G-protein coupled ER, GPR30, in spine maturation and stabilisation. 
GPR30 is localised in spine heads, associates with PSD-95, and is regulated by E2 
(163,164). In the dorsal hippocampus, the GPR30 agonist, G1, increases PSD-95 
immunoreactivity, suggesting a role for GPR30 in spine maturation (164). Indeed, this 
receptor has been implicated in the initiation of lordosis behaviour on the basis that the 
partial GPR30 agonist but ERα antagonist, ICI 182,780, facilitates lordosis in E2-primed 
nonreceptive rats (165). Other studies suggest there could be a role for the STX-activated 
Gq-coupled membrane ER in the ARH-MPN circuit mediating sexual receptivity. STX is a 
tamoxifen analogue that does not bind to classical ERα or GPR30 but is blocked by the ER 
antagonist ICI 182,780 and has pharmacological profile similar to those of the ERα-specific 
agonist, PPT (166–168). STX treatment induces μ-opioid receptor (MOR) internalisation in 
the MPN and facilitates lordosis behaviour (169). Alternatively, spine maturation could be 
mediated by extra-neuronal mechanisms, such as astrocytic contact with neurones, which 
alters dendritic spine formation and stabilisation (170).
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Additionally, it is unclear whether E2 induces spinogenesis in the same population of 
neurones in the ARH that express ERα, the neuropeptide Y (NPY) neurones, which are the 
initial site of the action of E2 in the ARH-MPN-VMH circuit, or whether E2 is acting 
transsynaptically to induce spines on pro-opiomelanocortin (POMC) neurones, which 
release β-endorphin onto MORs in the MPN. Recent data suggest that the NPY neurones 
and not POMC neurones undergo spinogenesis, suggesting that spine formation occurs 
directly within the neurones where initial E2 activation of ERα occurs (171). Regardless of 
the site of spinogenesis within the ARH, it is clear that spine maturation in this nucleus is 
coincident with lordosis behaviour, and also that blocking spinogenesis here reduces female 
sexual receptivity. To a first approximation, the timeline from E2 treatment to the presence of 
mature dendritic spines is known. However, the time when fully functional synapses appear 
remains to be determined. Within 1 h of E2 treatment, cofilin is deactivated via 
phosphorylation, which permits spinogenesis (162), and, in the MPN, MOR is activated/
internalised, indicating that the ARH to MPN part of the circuit is functional (172). At 4 h 
post-E2 treatment, filapodial spines are present, although these thin, labile spines are not 
considered to mediate functional synapses (173). At 20 h after E2 treatment, the first time 
point when lordosis behaviour can be elicited with supplemental hormone treatment, there is 
an increase in the proportion of mushroom spines that are generally assumed to be indicative 
of functional synapses (162) and that contain the machinery required for synaptic 
transmission (e.g. PSD-95). Future studies should address the time course of this E2-
dependent spine maturation and the potential involvement of non-traditional ER in this 
process.
Conclusions
Taken together, these recent findings highlight both the redundancy and complexity of the 
hormonal control of reproduction: what was once considered to be a simple, direct circuit 
with a handful of steroid hormones and cognate receptors is continually updated with novel 
hormone regulators and mechanisms of hormone synthesis and action. However, the 
classical aspects of gonadal hormone control of reproduction remain intact, demonstrating 
that there are multiple levels of control of the HPG axis, both centrally and peripherally. 
Future studies will likely only add to this increasingly complex circuit that regulates 
reproduction.
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Fig. 1. 
A model showing proposed actions of oestradiol (E2) on hypothalamic cells. In kisspeptin 
(Kiss1) neurones, E2 acts at both membrane and nuclear oestrogen receptors. During di-
oestrus, classical nuclear E2 signalling induces progesterone receptor (PR) expression in 
Kiss1 neurones in the rostral periventricular nucleus of the third ventricle (RP3V). On pro-
oestrus, rising E2 leads to transactivation of mGluR1a in astrocytes, which increases [Ca2+]i, 
leading to the conversion of cholesterol to pregnenolone (PREG) by the P450scc enzyme 
and the conversion of PREG to progesterone (neuroP) by 3β-hydroxysteroid dehydrogenase 
(HSD). Simultaneously, E2 activates an oestrogen receptor (ER)α-mGluR1a complex in 
neurones leading to the expression of Kiss1. Newly synthesised neuroP diffuses out of the 
astrocytes and activates E2-induced PR, which has been trafficked to the Kiss1 neuronal 
membrane. This leads to a series of events culminating in Kiss1 secretion onto GPR54 
expressing gonadotrophin-releasing hormone (GnRH) neurones. Signalling through PR in 
Kiss1 neurones induces Kiss1 release, activating GnRH neurones and triggering the E2-
induced luteinising hormone (LH) surge from anterior pituitary gonadotrophs. MAPK, 
mitogen-activated protein kinase.
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Fig. 2. 
Gonadotropin-Releasing Hormone (GnRH) peptide processing and action. The decapeptide, 
GnRH, is processed extracellularly to form the metabolite, GnRH-(1-5) by the zinc 
metalloendopeptidase, EC3.4.24.15 (EP24.15; 66, 73). The metabolite, GnRH-(1-5), exerts 
is biological activities via 2 putative receptors, the G-protein coupled receptors (GPR) 
GPR101 and GPR173 (70, 71).
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